Establishment Labs Corp (ESTA) Price to Earnings Ratio

Corporate emblem and logo of Establishment Labs Corp (ESTA)

Establishment Labs (ESTA) growth relies on US expansion and high product margins. The company's 12-month trailing P/E (TTM) dynamics on the GURU.Markets chart clearly illustrate the market valuation, where -54.10 determines the current status of the parameter. Production facilities in Costa Rica ensure global distribution. A robust patent portfolio and certification in 80 countries create a reliable barrier to entry for competitors.

Establishment Labs Inc (ESTA) Price to Earnings Ratio: for the period 07/04/2022 - 11/10/2026
Original product of establishmentlabs.com

The P/E ratio reflects the market value of a single unit of profit, allowing an investor to determine the investment payback period by comparing the current share price with the business's fundamental earnings. An analysis of the average P/E for Establishment Labs (ESTA) confirms that the company's technological dominance in the premium implant segment justifies its high market valuation, securing long-term potential for capital appreciation amid its expansion into aesthetic medicine.

Analysis of competing companies

P/E Multiple bostonscientific.com|Price to Earnings Ratio Edwards Lifesciences Corporation (EW)|Price to Earnings Ratio RMD (ResMed Inc)|P/E Multiple PODD (OmniPod)|Business Payback Period Zimmer Biomet (ZBH)|COO: Price to Earnings Ratio|Market Cap to Net Income ALGN|GMED: P/E Multiple|Market Cap to Earnings TransMedics Organ Care System (TMDX)|ATEC (ATEC Spine) - P/E Multiple|Price to Earnings Multiple AORT (Artivion Corp)|Price to Earnings Ratio ENOV (Enovis Corporation)|IART (integralife.com) - Company Value to Net Income|Price to Earnings Ratio Beta Bionics BBNX|IRMD - Price to Earnings Ratio|Embecta Inc. - P/E Multiple|Market Cap to Earnings Tandem Corp|AXGN: P/E Multiple|Price to Earnings Multiple SIBN|OFIX (Orthofix) - P/E Multiple|Bioventus Inc (BVS) - Business Payback Period|P/E Multiple KIDS|Price to Earnings Ratio Treace Corp TMCI|P/E Multiple SRTA (Strata Critical Medical Inc)|P/E Multiple carlsmed.com CARL|RXST - Price to Earnings Ratio|CLPT: Price to Earnings Ratio|STXS (Stereotaxis Corp) - Price to Earnings Ratio|Neuronetics, Inc - Company Value to Net Income|SGHT (Sight Sciences, Inc.) - P/E Multiple|Market Cap to Earnings orchestrabiomed.com OBIO|Price to Earnings Ratio Anika Therapeutics (ANIK)|InspireMD Inc (NSPR) - Market Cap to Net Income Ratio|Jin Medical - Price to Earnings Ratio|P/E Multiple Vivani Medical Inc VANI|Xtant Medical Inc - P/E Multiple|Business Payback Period n1mtc.com NMTC|modular-medical.com (MODD) - Price to Earnings Ratio|Market Cap to Net Income MYO (Myomo Inc.)|Price to Earnings Ratio Envoy Medical, Inc|Price to Earnings Ratio Vivos Therapeutics Inc (VVOS)|P/E Multiple NVNO|SINT - Market Cap to Earnings|Price to Earnings Ratio Tenon Medical TNON|LFWD: Price to Earnings Multiple|AMIX: Price to Earnings Ratio|INVO Fertility Corp - Market Price to Net Income Ratio|BBLG: P/E Multiple|Market Cap to Earnings axonics.com (AXNX)|Price to Earnings Ratio BIOLASE|Dynatronics Corp. (DYNT) - Business Payback Period|Price to Earnings Ratio FNA (Paragon 28, Inc.)|Market Price to Net Income Ratio INVO